Modulation of the CD95-induced apoptosis: The role of CD95 N-glycosylation

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Shatnyeva, Olga M ^a   Kubarenko, Andriy V ^a,b   Weber, Claudia E M ^a   Pappa, Alexander ^a,c   Schwartz Albiez, Reinhard ^a   Weber, Alexander N R ^a   Krammer, Peter H ^a   Lavrik, Inna N ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c MEDAC GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYMANNONOJIRIMYCIN; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; FAS ANTIGEN; GLYCOSYLATED PROTEIN; PROCASPASE 8; SIALIDASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; CASPASE 8; TNFSF10 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BIOINFORMATICS; CELLULAR DISTRIBUTION; COMPUTER MODEL; CONTROLLED STUDY; DEGLYCOSYLATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PREDICTION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN GLYCOSYLATION; SIGNAL TRANSDUCTION; THREE DIMENSIONAL IMAGING; VIBRIO CHOLERAE; WESTERN BLOTTING; BIOLOGY; CELL CULTURE; CHEMISTRY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GLYCOSYLATION; IMMUNOPRECIPITATION; LYMPHOCYTE; METABOLISM; MUTATION;

VIBRIO CHOLERAE;

ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CASPASE 8; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLYCOSYLATION; HUMANS; IMMUNOPRECIPITATION; LYMPHOCYTES; MUTATION; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 79956220755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019927     Document Type: Article

References (57)

1. Krammer PH, Arnold R, Lavrik IN, (2007) Life and death in peripheral T cells. Nat Rev Immunol 7: 532-542.
2. Lavrik I, Golks A, Krammer PH, (2005) Death receptor signaling. J Cell Sci 118: 265-267.
3. Suda T, Takahashi T, Golstein P, Nagata S, (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178.
4. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, et al. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305.
5. Lavrik IN, Golks A, Riess D, Bentele M, Eils R, et al. (2007) Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J Biol Chem 282: 13664-13671.
6. Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, et al. (2007) The CD95 receptor: apoptosis revisited. Cell 129: 447-450.
7. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, et al. (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14: 5579-5588.
8. Golks A, Brenner D, Fritsch C, Krammer PH, Lavrik IN, (2005) c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem 280: 14507-14513.
9. Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, et al. (2002) Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J 21: 4520-4530.
10. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827.
11. Scaffidi C, Medema JP, Krammer PH, Peter ME, (1997) FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 272: 26953-26958.
12. Lavrik I, Krueger A, Schmitz I, Baumann S, Weyd H, et al. (2003) The active caspase-8 heterotetramer is formed at the CD95 DISC. Cell Death Differ 10: 144-145.
13. Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, et al. (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288: 2354-2357.
14. Esposito D, Sankar A, Morgner N, Robinson CV, Rittinger K, et al. (2010) Solution NMR investigation of the CD95/FADD homotypic death domain complex suggests lack of engagement of the CD95 C terminus. Structure 18: 1378-1390.
15. Wang L, Yang JK, Kabaleeswaran V, Rice AJ, Cruz AC, et al. (2010) The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat Struct Mol Biol 17: 1324-1329.
16. Scott FL, Stec B, Pop C, Dobaczewska MK, Lee JJ, et al. (2009) The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature 457: 1019-1022.
17. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, et al. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687.
18. Peter ME, Hellbardt S, Schwartz-Albiez R, Westendorp MO, Walczak H, et al. (1995) Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. Cell Death Differ 2: 163-171.
19. Keppler OT, Peter ME, Hinderlich S, Moldenhauer G, Stehling P, et al. (1999) Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology 9: 557-569.
20. Li Y, Yang X, Nguyen AH, Brockhausen I, (2007) Requirement of N-glycosylation for the secretion of recombinant extracellular domain of human Fas in HeLa cells. Int J Biochem Cell Biol 39: 1625-1636.
21. Varki NM, Varki A, (2007) Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest 87: 851-857.
22. Varki A, (2008) Sialic acids in human health and disease. Trends Mol Med 14: 351-360.
23. Powell LD, Varki AP, (2001) Curr Protoc Mol Biol Sialidases.
24. Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, et al. (2007) Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med 13: 1070-1077.
25. Schmitz I, Krueger A, Baumann S, Kirchhoff S, Krammer PH, (2002) Specificity of anti-human CD95 (APO-1/Fas) antibodies. Biochem Biophys Res Commun 297: 459-462.
26. Neumann L, Pforr C, Beaudouin J, Pappa A, Fricker N, et al. (2010) Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol Syst Biol 6: 352.
27. Scaffidi C, Kischkel FC, Krammer PH, Peter ME, (2000) Analysis of the CD95 (APO-1/Fas) death-inducing signaling complex by high-resolution two-dimensional gel electrophoresis. Methods Enzymol 322: 363-373.
28. Feig C, Tchikov V, Schutze S, Peter ME, (2007) Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO J 26: 221-231.
29. Aerts JM, Brul S, Donker-Koopman WE, van Weely S, Murray GJ, et al. (1986) Efficient routing of glucocerebrosidase to lysosomes requires complex oligosaccharide chain formation. Biochem Biophys Res Commun 141: 452-458.
30. Bentele M, Lavrik I, Ulrich M, Stosser S, Heermann DW, et al. (2004) Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J Cell Biol 166: 839-851.
31. Krammer PH, (2000) CD95's deadly mission in the immune system. Nature 407: 789-795.
32. Strand S, Vollmer P, van den Abeelen L, Gottfried D, Alla V, et al. (2004) Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells. Oncogene 23: 3732-3736.
33. Ralph P, Saiki O, Maurer DH, Welte K, (1983) IgM and IgG secretion in human B-cell lines regulated by B-cell-inducing factors (BIF) and phorbol ester. Immunol Lett 7: 17-23.
34. Svedmyr E, Jondal M, (1975) Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci USA 72: 1622-1626.
35. Gootenberg JE, Ruscetti FW, Mier JW, Gazdar A, Gallo RC, (1981) Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J Exp Med 154: 1403-1418.
36. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, et al. (1965) Continuous Culture of Human Lymphoblasts from Peripheral Blood of a Child with Acute Leukemia. Cancer 18: 522-529.
37. Juo P, Kuo CJ, Yuan J, Blenis J, (1998) Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 8: 1001-1008.
38. Schneider U, Schwenk HU, (1977) Characterization of "T" and "non-T" cell lines established from children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after leukemic transformation. Haematol Blood Transfus 20: 265-269.
39. Li-Weber M, Weigand MA, Giaisi M, Suss D, Treiber MK, et al. (2002) Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J Clin Invest 110: 681-690.
40. Scherer WF, Syverton JT, Gey GO, (1953) Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med 97: 695-710.
41. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
42. Scaffidi C, Volkland J, Blomberg I, Hoffmann I, Krammer PH, et al. (2000) Phosphorylation of FADD/MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase. J Immunol 164: 1236-1242.
43. Scaffidi C, Schmitz I, Krammer PH, Peter ME, (1999) The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274: 1541-1548.
44. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, et al. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163.
45. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, et al. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267: 10709-10715.
46. Kubarenko A, Frank M, Weber AN, (2007) Structure-function relationships of Toll-like receptor domains through homology modelling and molecular dynamics. Biochem Soc Trans 35: 1515-1518.
47. Kubarenko A, Ranjan S, Colak E, George J, Frank M, et al. (2009) Comprehensive modeling and functional analysis of Toll-like receptor ligand-recognition domains. Protein Sci 19: 558-569.
48. Sali A, Overington JP, (1994) Derivation of rules for comparative protein modeling from a database of protein structure alignments. Protein Sci 3: 1582-1596.
49. Naismith JH, Devine TQ, Brandhuber BJ, Sprang SR, (1995) Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J Biol Chem 270: 13303-13307.
50. Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, et al. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73: 431-445.
51. Huang B, Eberstadt M, Olejniczak ET, Meadows RP, Fesik SW, (1996) NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 384: 638-641.
52. Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O'Connell M, et al. (1999) Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 4: 563-571.
53. Bohne-Lang A, von der Lieth CW, (2005) GlyProt: in silico glycosylation of proteins. Nucleic Acids Res 33: W214-219.
54. van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, et al. (2005) GROMACS: fast, flexible, and free. J Comput Chem 26: 1701-1718.
55. Melo F, Devos D, Depiereux E, Feytmans E, (1997) ANOLEA: a www server to assess protein structures. Proc Int Conf Intell Syst Mol Biol 5: 187-190.
56. Guex N, Peitsch MC, (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
57. Kubarenko AV, Ranjan S, Colak E, George J, Frank M, et al. (2010) Comprehensive modeling and functional analysis of Toll-like receptor ligand-recognition domains. Protein Sci.